August 2025
1. RAYNER H, van Wyk V
   Anrikefon for itching related to chronic kidney disease.
   BMJ. 2025;390:r1770.
   

   >> Share

   
   November 2024
2. 
   Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
   BMJ. 2024;387:q2605.
   

   >> Share

   
   October 2024
3. AGARWAL A, Zeng X, Li S, Rayner D, et al
   Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.
   BMJ. 2024;387:e080257.
   

   >> Share

   
   April 2024
4. LIU P, Sawhney S, Heide-Jorgensen U, Quinn RR, et al
   Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study.
   BMJ. 2024;385:e078063.
   

   >> Share

   
   
5. GERDS TA, Ravani P
   Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease.
   BMJ. 2024;385:q721.
   

   >> Share

   
   
6. KENGNE AP, George C, Ameh OI
   Predicting the outcomes of chronic kidney disease in older adults.
   BMJ. 2024;385:q749.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share